润本生物技术股份有限公司 2025 年第二次临时股东大会会议资料 润本生物技术股份有限公司 会议资料 润本生物技术股份有限公司 2025 年第二次临时股东大会会议资料 目 录 议案一：关于<2025 年半年度利润分配方案>的议案…………….………….…....7 议案二：《关于取消监事会暨修订 <公司章程> 的议案》……….………….…....8 议案三：《关于修订 <股东大会议事规则> 的议案》……….………….………....9 议案四：《关于修订 <董事会议事规则> 的议案》……….………….….….........10 议案九：《关于修订 <会计师事务所选聘制度> 的议案》……….………….…...15 议案十：《关于修订 <控股股东 实际控制人行为规范="实际控制人行为规范"> 的议案》……….……16 议案十一：《关于修订 <累积投票制实施细则> 的议案》……….………….…...17 议案十二：《关于修订 <募集资金管理制度> 的议案》……….………….….......18 润本生物技术股份有限公司 2025 年第二次临时股东大会会议资料 股东大会会议须知 为维护全体股东的合法权益，确保股东大会的 ...

资金流向方面，今日主力资金净流出5891.55万元，占比成交额24.08%。其中，超大单净流出5083.82万 元、占成交额20.77%，大单净流出807.72万元、占成交额3.3%，中单净流出流入1399.80万元、占成交 额5.72%，小单净流入4491.74万元、占成交额18.36%。 金融界消息 截至2025年8月25日收盘，润本股份（603193）报收于30.59元，下跌1.77%，换手率 7.73%，成交量7.99万手，成交金额2.45亿元。 通过天眼查大数据分析，润本生物技术股份有限公司共对外投资了8家企业，参与招投标项目13次，知 识产权方面有商标信息106条，专利信息109条，此外企业还拥有行政许可64个。 来源：金融界 润本股份最新一期业绩显示，截至2025中报，公司营业总收入8.95亿元、同比增长20.31%，归属净利润 1.88亿元，同比增长4.16%，扣非净利润1.77亿元，同比增长0.86%，流动比率10.497、速动比率9.660、 资产负债率6.98%。 天眼查商业履历信息显示，润本生物技术股份有限公司，成立于2013年，位于广州市，是一家以从事化 学原料和化学制品制造业为主的 ...

Group 1 - From August 18 to August 24, brokers issued a total of 463 target prices for listed companies, with the highest target price increases for Hengmingda at 63.83%, Jiangsu Shentong at 62.24%, and Dongfang Caifu at 60.29%, belonging to the consumer electronics, general equipment, and securities industries respectively [1] - A total of 559 listed companies received broker recommendations during the same period, with Beixin Building Materials receiving 22 recommendations, Yanghe Co. receiving 21, and Runben Co. receiving 20 [1] - During this period, brokers upgraded ratings for 9 companies, including Dongbei Securities upgrading Changhai Co. from "Hold" to "Buy", and Pacific Securities upgrading Chuanjinno from "Hold" to "Buy" [1] Group 2 - Brokers downgraded ratings for 11 companies, including Minsheng Securities downgrading Taoli Bread from "Recommended" to "Cautious Recommendation", and Zhongyin International Securities downgrading Southern Airlines from "Hold" to "Increase" [1] - From August 18 to August 24, brokers provided 97 instances of initial coverage, with Southern Airlines receiving an "Increase" rating from Zhongyin International Securities, and Cuihua Jewelry receiving a "Buy" rating from Tianfeng Securities [2] - Other companies receiving initial coverage include Feiyada with a "Buy" rating from Dongbei Securities, Lihua Co. with an "Increase" rating from Huaxi Securities, and Sanhuan Group with a "Buy" rating from Huayuan Securities [2]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The retail industry is experiencing a recovery, with high growth in premium and fashionable segments, particularly in gold jewelry and beauty care [23][27] - The report emphasizes the importance of emotional consumption themes driving growth in high-quality companies within the sector [30] Summary by Sections Retail Market Review - The retail industry index rose by 4.21% during the week of August 18-22, 2025, outperforming the Shanghai Composite Index by 2.20 percentage points [12][20] - The internet e-commerce sector showed the highest growth, with a weekly increase of 7.71% [13][17] - Year-to-date, the jewelry sector has led with a 33.74% increase [13][17] Retail Insights: Mid-Year Reports - Gold jewelry companies like Laopuhuang and Chaohongji reported significant revenue growth, with Laopuhuang achieving a revenue of 12.354 billion yuan (+251.0%) and a net profit of 2.268 billion yuan (+285.8%) [23][35] - Beauty care brands such as Shanghai Jahwa and Runben also showed positive performance, with Shanghai Jahwa reporting a net profit of 266 million yuan (+11.7%) [27][38] Focus on High-Quality Companies - Investment focus includes: - Gold jewelry brands with differentiated product offerings, recommending Laopuhuang and Chaohongji [30][32] - Offline retail companies adapting to trends, recommending Yonghui Supermarket and Aiyingshi [30][32] - High-quality domestic beauty brands, recommending Maogeping and Pola [30][32] - Medical beauty product manufacturers, recommending Aimeike and Kedi-B [30][32] Company-Specific Highlights - Laopuhuang: Achieved a revenue of 12.354 billion yuan (+250.9%) and a net profit of 2.268 billion yuan (+285.8%) in H1 2025, with strong brand expansion and channel upgrades [35][36] - Runben: Reported a revenue of 895 million yuan (+20.3%) and a net profit of 188 million yuan (+4.2%) in H1 2025, focusing on expanding its product matrix [38][40] - Aiyingshi: Achieved a revenue of 1.835 billion yuan (+8.3%) and a net profit of 46.74 million yuan (+10.2%) in H1 2025, with steady store expansion [42]

Macro Insights - The economic growth rate in August is expected to be supported by exports and consumption policies, despite a significant slowdown in the real estate sector, with a target of 5% annual growth remaining achievable [1][15][12] - The industrial added value in July grew by 5.7% year-on-year, with the manufacturing sector showing resilience, particularly in high-tech products and equipment manufacturing [12][13] - Fixed asset investment growth slowed to 1.6% year-on-year in the first seven months, primarily due to a decline in real estate investment, which fell by 12% [13][14] Strategy Insights - Current channels for resident capital entering the market include increasing financing balances and active personal investor accounts, leading to a positive feedback loop in the market [2] - The "anti-involution" market trend can be analyzed through policy expectations and real-world transmission, indicating a shift from theme-driven to profit-driven market dynamics [2] - The technology and small-cap sectors are expected to continue outperforming as more external funds enter the market [2] Industry Reports - The consumer electronics sector is anticipated to see significant opportunities with the upcoming release of new products, particularly in AI-related applications [8] - The coal mining industry is experiencing a continuous improvement in fundamentals, with the price of thermal coal expected to rise [8] - The healthcare sector, particularly innovative drugs, is projected to maintain a positive outlook due to improved profitability [8]

Market Overview - The personal care products sector increased by 0.74% on August 21, with Jieya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Stock Performance - Jieya Co., Ltd. (301108) closed at 30.18, up 10.23% with a trading volume of 73,200 shares and a turnover of 219 million yuan [1] - Yiyi Co., Ltd. (001206) closed at 27.01, up 3.17% with a trading volume of 99,000 shares and a turnover of 265 million yuan [1] - Zhongshun Jierou (002511) closed at 8.91, up 2.65% with a trading volume of 450,700 shares and a turnover of 403 million yuan [1] - Other notable performances include: - Liangmian Needle (600249) up 1.36% - Beijia Clean (603059) up 1.13% - Wanjian Medical (300888) up 0.62% [1] Capital Flow - The personal care products sector experienced a net outflow of 42.6484 million yuan from institutional investors, while retail investors saw a net inflow of 67.9388 million yuan [2] - The detailed capital flow for key stocks shows: - Wanjian Medical had a net inflow of 23.3464 million yuan from institutional investors [3] - Jieya Co., Ltd. had a net inflow of 9.9211 million yuan from institutional investors [3] - Zhongshun Jierou had a net inflow of 1.121 million yuan from retail investors [3]

2025H1 营收同比+20.3%，归母净利润同比+4.2% 公司发布半年报：2025H1 实现营收8.95 亿元（同比+20.3%，下同）、归母净利润1.88 亿元 （+4.2%）；2025Q2 实现营收6.55 亿元（+13.5%）、归母净利润1.43亿元（-0.9%）；此外，公司拟每 10 股派发现金红利2.00 元（含税），分红率43.15%。 考虑市场竞争激烈，我们下调2025-2027 年盈利预测，预计公司2025-2027 年归母净利润为3.32/4.24/5.34 亿元（原值3.91/4.99/6.24 亿元），对应EPS 为0.82/1.05/1.32 元，当前股价对应PE 为37.5/29.4/23.3 倍。 我们认为，公司作为"驱蚊+婴童护理"细分龙头，不断丰富产品矩阵，规模优势持续巩固，估值合理， 维持"买入"评级。 婴童护理系列贡献收入上升，销售投放略加大 分品类看，2025H1 公司婴童护理/驱蚊/精油业务分别实现营收4.05/3.75/0.92 亿元，同比分别 +38.7%/+13.4%/-14.6%，婴童护理贡献收入同比提升，达45.3%，驱蚊业务在夏季启动较晚背景下增速 放缓 ...

开源证券8月20日发布研报称，给予润本股份（603193.SH，最新价：30.77元）买入评级。评级理由主 要包括：1）2025H1营收同比+20.3%，归母净利润同比+4.2%；2）婴童护理系列贡献收入上升，销售 投放略加大。风险提示：消费意愿下行、新品不及预期、过度依赖营销、市场竞争加剧。 （文章来源：每日经济新闻） ...

智通财经记者 | 朱咏玲 智通财经编辑 | 楼婍沁 夏季通常是驱蚊产品的旺季，但主营驱蚊产品的日化企业润本股份在今年二季度表现并不如预期理想。 值得注意的是，利好驱蚊产品销售的基孔肯雅热疫情没能帮上忙，其首次在中国内地出现传播案例是在 7月，并不在二季度的范畴内。 根据润本股份发布的二季度经营数据，润本股份二季度的驱蚊产品营收同比增长14%至3.32亿元。而在 2021年到2024年，驱蚊产品的年增速一直保持在19%到35%之间波动。 这也导致，润本股份二季度的总营收和归母净利润增速分别为13.46%和-0.85%，明显低于一季度的 44.00%和24.60%。整个2025年上半年，润本股份的营收和归母净利润增速显著低于往年。 由于六神母公司上海家化，以及雷达、欧护母公司庄臣控股尚未发布半年度财报，暂无法确认其他驱蚊 品牌的表现。 但多份研报认为，润本股份二季度表现为阶段性承压，它们对润本股份下半年业绩仍持乐观预期，认为 新品尤其是婴童品类及渠道扩展有望带动业绩回暖。 比起驱蚊业务，润本股份的婴童护理业务表现更为亮眼，其在二季度增速达23%，快于驱蚊业务；整个 上半年的收入和增速也都超过了驱蚊业务。 (选填) ...

"秋后的蚊子猛于虎"，每年北京的初秋、中秋都是蚊虫活跃时期，加上基孔肯雅热疫情，防蚊驱蚊产品受到颇多 关注。不过，市场需求的提升也伴随一些问题，如无"三证"产品当作防蚊驱蚊产品售卖，以"嗡""叮"等字眼暗示 驱蚊功效，货不对板，甚至一些"三无"产品也在市场销售。 近期，新京报记者从线下超市、连锁店及多家电商平台购买了24款防蚊驱蚊产品，包括蚊香、驱蚊花露水、驱蚊 液、防护贴（含精油贴）、驱蚊喷雾等，购买渠道涉及电商、便利店、商超等。 总体来看，蚊香、驱蚊花露水等传统驱蚊产品对农药登记证号、产品标准号以及农药生产许可证号（即"三证"） 的标志较为规范。无论线下还是电商平台，以天然成分、植物萃取等为卖点的防护贴、驱蚊手环类产品，则在实 际销售中以"防叮""远离夏季嗡嗡滋扰"等内容，打起了防蚊驱蚊擦边球。另外，24款产品中，有15款未在外包装 中标注"三证"，其中防护贴、防护手环占比达三分之二。 问题1 以远离"嗡""防叮"擦边驱蚊，防护贴、手环居多 据农业农村部2021年9月发布的《关于防蚊驱蚊类产品认定的意见》，如果产品的标签、说明书标明该产品具有防 蚊驱蚊功能，无论其有效成分是化学成分还是植物源性成分，该产品 ...